A new preprint study details a method of deactivating the genetic alteration effects of Covid mRNA jabs, providing a glimmer of hope to the billions of humans who have been damaged by the experimental shots.
“The Pfizer-BioNTech and Moderna biodistribution studies refute the assertion that nanolipid-bound nms-mRNA remains in the deltoid muscle or axillary lymph nodes. Detectable vaccine mRNA levels remaining in various tissues raises potential safety concerns,” the study declared in the ‘Conclusions’ section. “The possibility of vaccine mRNA integration into the host genome and the prospect of unintended protein production due to read through advocate for a mechanism to eliminate lingering synthetic mRNA and halt damaging Spike protein production. The use of siRNA and RIBOTACs to target and degrade vaccine mRNA are promising approaches to mitigate deleterious health effects. The ability to readily tailor the siRNA and RIBOTACs to target an mRNA of interest makes these techniques particularly appealing, although further investigation is warranted to address challenges which include possible off-target effects and immune system activation.”
Infowars.com reports: Messenger RNA (mRNA) technology, referred to in Moderna’s patents as modified mRNA or mmRNA for modified messenger RNA, is an exotic technology that encapsulates an altered RNA sequence within a lipid nanoparticle so as to introduce it into the cells of the vaccinated individual. The foreign man-made sequence is then incorporated into the cells of the vaccinated individual, thus acting more as a gene therapy than a traditional vaccine.
While the exotic injection makes the individual begin to produce the dangerous Covid spike protein, currently there is no way to stop the individual from producing that spike protein forever. There is no ‘off’ switch, at least until now.
The study described a method of turning off the production of the spike protein.
“…the longevity of the encapsulated mRNA along with unlimited production of the damaging and potentially lethal Spike (S) protein call for strategies to mitigate potential adverse effects,” the study said in the ‘Abstract’ section. “Here, we explore the potential of small interfering RNA (siRNA) and ribonuclease targeting chimeras (RIBOTACs) as promising solutions to target, inactivate, and degrade residual and persistent vaccine mRNA, thereby potentially preventing uncontrolled Spike protein production and reducing toxicity. The targeted nature of siRNA and RIBOTACs allows for precise intervention, offering a path to prevent and mitigate adverse events of mRNA-based therapies.”
BREAKING - Our new study finds promising methods to deactivate mRNA COVID-19 vaccines and shut off spike protein production.
— McCullough Foundation (@McCulloughFund) May 31, 2024
Small interfering RNA (siRNA) and ribonuclease targeting chimeras (RIBOTACs) are promising solutions to target, inactivate, and degrade residual and… pic.twitter.com/eBpRW0zygo
The study detailed the method the researchers proposed to turn off the mutagenic effects of the Covid vaccines in the ‘siRNA and RIBOTAC Applications’ section.
The researchers also provided a graphical depiction of their proposed novel treatment.
Due to foreign messenger RNA being easily broken down by the body, Moderna (who developed the mRNA Covid vaccine which Pfizer copied and got sued for) devised a method of encapsulating the mRNA payload within a lipid nanoparticle which allowed it’s transport into the cell’s ribosomes. The study describes how many different bodily systems the exotic mRNA vaccine technology had to overcome in order to alter the human genome.
“Prior to the authorization of the Moderna (mRNA-1273) and Pfizer-BioNTech (BNT162b2) mRNA vaccines in 2020, numerous challenges were addressed to circumvent inherent limitations of mRNA technology. Although researchers previously demonstrated that nucleic acid could be encapsulated and successfully delivered via polymer particles, the advent of mRNA as an effective therapeutic agent required the mitigation of mRNA instability and immunogenicity as well as the ability of mRNA to cross multiple barriers [1, 2]. Even when mRNAs evade nucleases in the extracellular space and target cells, most of the mRNAs become trapped in endosomes and are subsequently degraded [3]. Additionally, endocytosis of exogenous mRNA can induce pattern-recognition receptor-mediated immunogenicity with subsequent inhibition of mRNA translation and reduced mRNA stability [4-8]. Furthermore, efficient mRNA delivery is hampered by the negative charges of the mRNA and the cell membrane[2]. Administered mRNA can also be removed by macrophage phagocytosis or through renal filtration[2],” the study said in the ‘Introduction’ section.
The researches discussed the prevalence of mRNA distribution in the vaccinated’s bodies.
“Research by Pardi et al. using a murine model demonstrates that LNP-encapsulated mRNAs injected subcutaneously, intramuscularly, or intradermally translate for up to 10 days [44]. Surprisingly, full length or fragments of vaccine SARS-CoV-2 Spike mRNA were observed in 9.3% of patients’ blood up to 28 days following administration of the mRNA-1273 or BNT162b2 mRNA vaccine [45]. The authors surmise that the mRNA detected in plasma is encased within LNPs since naked mRNA would rapidly degrade. Similarly, vaccine mRNA was observed in the germinal centers of lymph nodes 60 days after the second dose of mRNA-1273 or BNT162b2 was administered [46]. Furthermore, a study by Hanna et al. substantiates earlier findings that vaccine mRNA leaves the injection site to distribute systemically. The breast milk of 13 lactating women who had received either the BNT162b2 or mRNA-1273 COVID-19 vaccine was assessed for vaccine mRNA. Trace amounts of vaccine mRNA which displayed reduced integrity were detected in some breast milk samples up to 45h post-vaccination [47],” the study said in the ‘Detection of Vaccine mRNA In Vivo‘ section.
